AL-LAD

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
AL-LAD
AL-LAD structure.svg
Systematic (IUPAC) name
6-Allyl-6-nor-lysergic acid diethylamide
Clinical data
Legal status
  • UK: Class A
  • Illegal in Denmark, Sweden and Switzerland
Identifiers
CAS Number 65527-61-9 N
PubChem CID: 15227511
ChemSpider 21106248 YesY
UNII 020O2SR91L YesY
ChEMBL CHEMBL281787 YesY
Chemical data
Formula C22H27N3O
Molecular mass 349.4713 g/mol
 NYesY (what is this?)  (verify)

AL-LAD, also known as 6-allyl-6-nor-LSD, is a psychedelic drug and an analog of lysergic acid diethylamide (LSD). It is described by Alexander Shulgin in the book TiHKAL (Tryptamines i Have Known And Loved). It is synthesized starting from LSD as a precursor, using allyl bromide as a reactant.

Effects in humans

AL-LAD on blotter paper

While AL-LAD has subtly different effects than LSD, and appears to be slightly shorter lasting, their potencies are similar;[1] an active dose of AL-LAD is reported to be between 80 and 160 micrograms.[2] AL-LAD has a known but short and highly uncommon history of recreational human use, which originated in Ireland and the UK, but spread internationally.

Chemistry

AL-LAD does not cause a color change with the Marquis, Mecke or Mandelin reagents,[3] but does cause the Ehrlich's reagent to turn purple because of the presence of the indole moiety in its structure.

Legal status

On June 10th 2014 the UK Advisory Council on the Misuse of Drugs (ACMD) recommended that AL-LAD be specifically named in the UK Misuse of Drugs Act as a class A drug despite not identifying any harm associated with its use.[4] The UK Home office accepted this advice and announced a ban of the substance to be enacted on 6 January 2015 as part of The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014.

AL-LAD is illegal in Switzerland,[5] Sweden[6] and Denmark.[7]

See also

References

  1. Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  2. Shulgin, Alexander (1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. p. 392. ISBN 0-9630096-9-9.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  3. Ecstasydata. "EcstasyData.org - AL-LAD (Not sold as ecstasy)". Retrieved 2013-12-25.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  4. ACMD (10 June 2014). "Update of the Generic Definition for Tryptamines" (PDF). UK Home Office. p. 12. Retrieved 10 June 2014.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  5. "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" (in German). Der Bundesrat. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  6. "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015. <templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  7. "Lists of euphoriant substances". The Danish Medicines Agency. September 2015.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>

Additional literature

  • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  • Lua error in Module:Citation/CS1/Identifiers at line 47: attempt to index field 'wikibase' (a nil value).
  • Niwaguchi, T; Nakahara, Y; Ishii, H (1976). "Studies on lysergic acid diethylamide and related compounds. IV. Syntheses of various amide derivatives of norlysergic acid and related compounds". Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 96 (5): 673–8. PMID 987200.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  • Robert C. Pfaff, Xuemei Huang, Danuta Marona-Lewicka, Robert Oberlender and David E. Nichols: Lysergamides Revisited. In: NIDA Research Monograph 146: Hallucinogens: An Update. p. 52, 1994, United States Department of Health and Human Services.

External links